These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11216961)

  • 21. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I.
    Christen WG; Ajani UA; Schaumberg DA; Glynn RJ; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Mar; 119(3):405-12. PubMed ID: 11231774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
    Lee IM; Cook NR; Manson JE; Buring JE; Hennekens CH
    J Natl Cancer Inst; 1999 Dec; 91(24):2102-6. PubMed ID: 10601381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final report on the aspirin component of the ongoing Physicians' Health Study.
    Steering Committee of the Physicians' Health Study Research Group
    N Engl J Med; 1989 Jul; 321(3):129-35. PubMed ID: 2664509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline characteristics of participants in the Physicians' Health Study: a randomized trial of aspirin and beta-carotene in U.S. physicians.
    Manson JE; Buring JE; Satterfield S; Hennekens CH
    Am J Prev Med; 1991; 7(3):150-4. PubMed ID: 1931143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol consumption and risk of coronary heart disease by diabetes status.
    Ajani UA; Gaziano JM; Lotufo PA; Liu S; Hennekens CH; Buring JE; Manson JE
    Circulation; 2000 Aug; 102(5):500-5. PubMed ID: 10920060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians.
    Camargo CA; Stampfer MJ; Glynn RJ; Gaziano JM; Manson JE; Goldhaber SZ; Hennekens CH
    Circulation; 1997 Feb; 95(3):577-80. PubMed ID: 9024142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
    Sesso HD; Buring JE; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Glynn RJ; Gaziano JM
    JAMA; 2008 Nov; 300(18):2123-33. PubMed ID: 18997197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study.
    Ma J; Hennekens CH; Ridker PM; Stampfer MJ
    J Am Coll Cardiol; 1999 Apr; 33(5):1347-52. PubMed ID: 10193737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators.
    Mueller HS; Forman SA; Menegus MA; Cohen LS; Knatterud GL; Braunwald E
    J Am Coll Cardiol; 1995 Oct; 26(4):900-7. PubMed ID: 7560615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of low-dose aspirin in polycythemia vera.
    Landolfi R; Marchioli R; Kutti J; Gisslinger H; Tognoni G; Patrono C; Barbui T;
    N Engl J Med; 2004 Jan; 350(2):114-24. PubMed ID: 14711910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.
    Christen WG; Glynn RJ; Ajani UA; Schaumberg DA; Chew EY; Buring JE; Manson JE; Hennekens CH
    Arch Ophthalmol; 2001 Aug; 119(8):1143-9. PubMed ID: 11483080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly).
    Wassertheil-Smoller S; Applegate WB; Berge K; Chang CJ; Davis BR; Grimm R; Kostis J; Pressel S; Schron E
    Arch Intern Med; 1996 Mar; 156(5):553-61. PubMed ID: 8604962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study.
    Ariyo A; Hennekens CH; Stampfer MJ; Ridker PM
    J Cardiovasc Risk; 1998 Aug; 5(4):273-8. PubMed ID: 9919476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.
    Hayden M; Pignone M; Phillips C; Mulrow C
    Ann Intern Med; 2002 Jan; 136(2):161-72. PubMed ID: 11790072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
    Pietinen P; Rimm EB; Korhonen P; Hartman AM; Willett WC; Albanes D; Virtamo J
    Circulation; 1996 Dec; 94(11):2720-7. PubMed ID: 8941095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abdominal and total adiposity and risk of coronary heart disease in men.
    Rexrode KM; Buring JE; Manson JE
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1047-56. PubMed ID: 11443505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.